P1.23. Clinical Utility of Combined Plasma and Tissue NGS in Patients with Advanced, Treatment-Naïve, Non-small Cell Lung Cancer - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Helena Bote de Cabo
Meta Tag
Speaker Helena Bote de Cabo
Topic Pathology & Biomarkers: Liquid Based Biomarkers
clinical utility
tissue NGS
plasma NGS
detect actionable alterations
advanced non-small cell lung cancer
Oncomine Focus Assay
Guardant360 CDx
FoundationOne Liquid CDx
cohort 1
cohort 2
Powered By